Nonsense Mutations inFGF8Gene Causing Different Degrees of Human Gonadotropin-Releasing Deficiency
Author(s) -
Ericka Barbosa Trarbach,
Ana Paula Abreu,
Letícia Ferreira Gontijo Silveira,
Heraldo Mendes Garmes,
Maria Tereza Matias Baptista,
Milena Gurgel Teles,
Elaine Maria Frade Costa,
Moosa Mohammadi,
Nelly Pitteloud,
Berenice B. Mendonça,
Ana Claudia Latrônico
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2010-0176
Subject(s) - kallmann syndrome , endocrinology , nonsense mutation , medicine , hypogonadotropic hypogonadism , genetics , fgf8 , biology , missense mutation , proband , anosmia , mutation , gene , fibroblast growth factor , receptor , hormone , disease , covid-19 , infectious disease (medical specialty)
FGFR1 mutations cause isolated hypogonadotropic hypogonadism (IHH) with or without olfactory abnormalities, Kallmann syndrome, and normosmic IHH respectively. Recently, missense mutations in FGF8, a key ligand for fibroblast growth factor receptor (FGFR) 1 in the ontogenesis of GnRH, were identified in IHH patients, thus establishing FGF8 as a novel locus for human GnRH deficiency.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom